| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 8.220 | 30.260 | 20.538 | 22.549 | 18.841 | 11.410 | 8.528 |
| Total Income - EUR | - | - | - | 8.220 | 30.260 | 20.538 | 22.549 | 18.841 | 11.410 | 8.528 |
| Total Expenses - EUR | - | - | - | 7.820 | 1.385 | 16.075 | 21.649 | 15.065 | 6.739 | 8.525 |
| Gross Profit/Loss - EUR | - | - | - | 400 | 28.875 | 4.463 | 900 | 3.775 | 4.671 | 3 |
| Net Profit/Loss - EUR | - | - | - | 153 | 27.967 | 3.847 | 223 | 3.210 | 3.924 | 2 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Getrans Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 2.343 | 1.451 | 999 |
| Current Assets | - | - | - | 11.700 | 38.005 | 524.689 | 11.840 | 5.727 | 11.266 | 10.813 |
| Inventories | - | - | - | 10.989 | 36.610 | 510.386 | 11.106 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 722 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | 711 | 673 | 14.303 | 734 | 5.727 | 11.266 | 10.813 |
| Shareholders Funds | - | - | - | 196 | 28.159 | 4.597 | 4.718 | 7.942 | 11.843 | 11.779 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 11.504 | 9.846 | 520.092 | 7.122 | 128 | 875 | 33 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Getrans Medical S.r.l.